OP 6.5 – 00164 Nanobody-engineered AAV vectors for CD4-targeted gene therapy

• U. Lange,
• M. Hamann,
• D. Foth,
• P. Kumar,
• U.C. Lange

Affiliations

U. Lange

Leibniz Institute of Virology, Hamburg, Germany

M. Hamann

Leibniz Institute of Virology, Hamburg, Germany

D. Foth

Leibniz Institute of Virology, Hamburg, Germany

P. Kumar

Yale School of Medicine, New Haven, USA

U.C. Lange

Leibniz Institute of Virology, Hamburg, Germany; Institute for Infection Research and Vaccine Development, University Medical Center Hamburg, Eppendorf, Hamburg, Germany